Michele Spinicci - Concepedia

Author

Michele Spinicci

Also Known As

M Spinicci, M. Spinicci, Maria Teresa Cirasa, Michele SPINICCI, Michele Spinicci, Michele Trotta, Spinicci, M, Susanna Cozzio, Viviana Scancassani, the AOU Careggi COVID-19 Follow-up Study Group

128

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

University of Florence Azienda Ospedaliero-Universitaria Careggi University of Pisa Vita-Salute San Raffaele University Sapienza University of Rome

About

Michele Spinicci is an author at University of Florence specializing in medicine, covid-19, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	420
2	Epidemiology	4	4	244
3	Public Health	3	3	232
4	Health Sciences	1	1	31
5	Cell Biology	1	1	49

Michele Spinicci

Publications

1.9K

Citations

H-Index

Page 1

	Year	Citations
Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent Alessio Mazzoni, Lorenzo Salvati, Laura Maggi, Journal of Clinical Investigation	2020	524
First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19 Alessio Mazzoni, Nicoletta Di Lauria, Laura Maggi, Journal of Clinical Investigation	2021	146
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study Augusto Di Castelnuovo, Simona Costanzo, Andrea Antinori, European Journal of Internal Medicine MedicineHealthcare-associated InfectionClinical EpidemiologyCovid-19 PandemicCovid-19 Epidemiology	2020	112
Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 in a Preliminary Study Alessandra Vultaggio, Emanuele Vivarelli, Gianni Virgili, The Journal of Allergy and Clinical Immunology In Practice	2020	80
The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19 Martina Orlandi, Nicholas Landini, Gianluca Sambataro, Lara D. Veeken	2021	67
Early experience of an infectious and tropical diseases unit during the coronavirus disease (COVID-19) pandemic, Florence, Italy, February to March 2020 Filippo Lagi, Matteo Piccica, Lucia Graziani, Eurosurveillance Virus EpidemiologyDisease OutbreakCovid-19 EpidemiologyTropical Diseases UnitCovid-19	2020	64
Cell‐mediated and humoral adaptive immune responses to SARS‐CoV‐2 are lower in asymptomatic than symptomatic COVID‐19 patients Alessio Mazzoni, Laura Maggi, Manuela Capone, European Journal of Immunology Serum Virus-specific IgmAdaptive Immune SystemHumoral ResponseImmunologyImmunologic Mechanism	2020	63
Schistosomiasis, strongyloidiasis and Chagas disease: the leading imported neglected tropical diseases in Italy Lorenzo Zammarchi, Federico Gobbi, Andrea Angheben, Journal of Travel Medicine	2019	59
Low risk of serological cross-reactivity between dengue and COVID-19 Michele Spinicci, Alessandro Bartoloni, Antonia Mantella, Memórias do Instituto Oswaldo Cruz VaccinationHealth SystemsVirus EpidemiologyViral DiagnosticsEmerging Infectious Diseases	2020	56
SARS-CoV-2 Spike-Specific CD4+ T Cell Response Is Conserved Against Variants of Concern, Including Omicron Alessio Mazzoni, Anna Vanni, Michele Spinicci, Frontiers in Immunology Adaptive Immune SystemImmunologyCd4 T Cell ResponsesImmunotherapyBroad-spectrum Vaccines	2022	49

Page 1